l 738167 and l 734217
l 738167 has been researched along with l 734217 in 4 studies
Compound Research Comparison
| Studies (l 738167) | Trials (l 738167) | Recent Studies (post-2010) (l 738167) | Studies (l 734217) | Trials (l 734217) | Recent Studies (post-2010) (l 734217) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 8 | 0 | 0 |
Protein Interaction Comparison
| Protein | Taxonomy | l 738167 (IC50) | l 734217 (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.0275 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.0275 |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Askew, BC; Baldwin, JJ; Bednar, B; Bednar, RA; Claremon, DA; Cook, JJ; Gaul, SL; Glass, JD; Gorham, LM; Gould, RJ; Hamill, T; Hartman, GD; Holahan, MA; Hunt, CA; Lynch, JJ; Lynch, RJ; McIntyre, CJ; Prueksaritanont, T; Sitko, GR; Stranieri, MT | 1 |
| Askew, BC; Bednar, B; Bednar, RA; Brashear, K; Breslin, MJ; Duggan, ME; Egbertson, MS; Fisher, TE; Gould, RJ; Halczenko, W; Hartman, GD; Hutchinson, JH; Ihle, N; Prugh, JD; Wai, JS | 1 |
| Gretler, DD; Scarborough, RM | 1 |
| Bednar, B; Bednar, RA; Cook, JJ; Cunningham, ME; Gould, RJ; Hartman, GD; Holahan, MA; Jumes, PA | 1 |
Reviews
1 review(s) available for l 738167 and l 734217
| Article | Year |
|---|---|
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms | 2000 |
Other Studies
3 other study(ies) available for l 738167 and l 734217
| Article | Year |
|---|---|
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists.
Topics: Adenosine Diphosphate; Animals; Azepines; Blood Platelets; Collagen; Dogs; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Fibronectins; Humans; Molecular Structure; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship; Sulfonamides; Vitronectin | 1997 |
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors.
Topics: Amides; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship | 2000 |
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azepines; beta-Alanine; Blood Platelets; Disease Susceptibility; Dogs; Epitopes; Female; Fibrinolytic Agents; Humans; Immunoglobulin G; Macaca mulatta; Macromolecular Substances; Male; Molecular Structure; Oligopeptides; Pan troglodytes; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Primates; Protein Binding; Sulfonamides; Thrombocytopenia | 1999 |